Rankings
▼
Calendar
BIIB Q4 2016 Earnings — Biogen Inc. Revenue & Financial Results | Market Cap Arena
BIIB
Biogen Inc.
$28B
Q4 2016 Earnings
Healthcare
Drug Manufacturers - General
Income Statement
Revenue
$2.9B
Gross Profit
$2.5B
88.6% margin
Operating Income
$886M
30.9% margin
Net Income
$649M
22.6% margin
EPS (Diluted)
$2.99
QoQ Revenue Growth
-2.8%
Cash Flow
Operating Cash Flow
$1.6B
Free Cash Flow
$1.4B
Stock-Based Comp.
$37M
Balance Sheet
Total Assets
$22.9B
Total Liabilities
$10.7B
Stockholders' Equity
$12.1B
Cash & Equivalents
$2.3B
← FY 2016
All Quarters
Q1 2017 →